TMDX(TransMedics Group, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $30.26M | $93.46M | $241.62M | $441.54M | $605.49M |
| 毛利润 | $21.16M | $65.27M | $154.09M | $262.08M | $362.81M |
| 营业利润 | −$39.43M | −$31.44M | −$28.73M | $37.50M | $108.58M |
| 净利润 | −$44.22M | −$36.23M | −$25.03M | $35.46M | $190.29M |
| 经营现金流 | −$28.86M | −$45.82M | −$13.03M | $48.80M | $192.84M |
| 自由现金流 | −$32.38M | −$57.72M | −$164.88M | −$80.94M | $133.59M |
| 摊薄每股收益 | $-1.60 | $-1.23 | $-0.77 | $1.01 | $4.87 |